/

Empresas

Co

No verificado

Confo Therapeutics

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

2 Comunicados de prensa

Ver todos los comunicados de prensa

01/10/2024

Industria

Salud

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

Confo Therapeutics Announces Publication in Nature Communications Demonstrating First-Ever Structure of a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety

Fuente

Confo Therapeutics

Editor

1.00

0

26/07/2024

Ciencia

Biotecnología

Farmacéutica

Salud

Medicina - Varios

Sanidad

Confo Therapeutics Announces EUR 60M Series B Financing to Advance Pipeline of Novel GPCR-Modulating Therapies into Clinical Development

Fuente

Confo Therapeutics

Editor

1.00

0

Seguidores

0

Compatibilidad

0